Results
1 -
10 of
26
(Click
here to explore results)
- Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation, Chapter 7 Isoquinolines. Esther S. Roesch
, 2016
, Pages 147-213
- Emerging Drugs and Targets for Multiple Sclerosis, CHAPTER 8 Protein Kinase Inhibitors for the Treatment of Multiple Sclerosis. Ana Martinez, Carmen Gil
, 2019
, Pages 170-196
- Kinase Drug Discovery, Chapter 7 The Drug Discovery and Development of Kinase Inhibitors Outside of Oncology. A. J. Ratcliffe
, 2012
, Pages 218-243
- Drug Repurposing, Chapter 3 The Role of Clinical Medicine. Richard K. Wyse, Antony A. Cooper, Simon R. W. Stott
, 2022
, Pages 24-51
- Environmental Cardiology: Pollution and Heart Disease, Chapter 4 Hypertension and Vascular Toxicity of PM. Z. Ying, S. Rajagopalan
, 2011
, Pages 121-142
- Anti-fibrotic Drug Discovery, CHAPTER 1 TGFβ Signaling. Anne-Ulrike Trendelenburg
, 2020
, Pages 1-36
- Orphan Drugs and Rare Diseases, Chapter 13 Treatments for Pulmonary Arterial Hypertension. Michael J. Palmer
, 2014
, Pages 369-397
- Designing Multi-Target Drugs, Chapter 4 Chemoinformatic Approaches to Target Identification. Elisabet Gregori-Puigjané, Michael J. Keiser
, 2012
, Pages 50-65
- Biomaterial Based Approaches to Study the Tumour Microenvironment, Chapter 15 Tissue-engineered Cancer Models in Drug Screening. R. Cao, A. Fomina, A. P. McGuigan
, 2023
, Pages 415-449
- Drug Repurposing, Chapter 8 Using Artificial Intelligence for Drug Repurposing. A. Bender
, 2022
, Pages 147-172